Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study Group. (Q53270825)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 2011

Language	Label	Description	Also known as
English	Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study Group.	scientific article published in February 2011

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study Group. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Hiroaki Goto

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Takeshi Inukai

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Hiroyasu Inoue

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Chitose Ogawa

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Takashi Fukushima

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Miharu Yabe

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Akira Kikuchi

7

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Kazutoshi Koike

8

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Keitaro Fukushima

9

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Keiichi Isoyama

10

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Tomohiro Saito

11

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Akira Ohara

12

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Ryoji Hanada

13

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Jiro Iwamoto

14

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Noriko Hotta

15

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Yoshihisa Nagatoshi

16

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Jun Okamura

17

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Masahiro Tsuchida

18

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

publication date

1 February 2011

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

International Journal of Hematology

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

93

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

192-198

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

https://scigraph.springernature.com/pub.10.1007/s12185-011-0765-3

0 references

The management of neoplastic disorders of haematopoiesis in children with Down's syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Trisomy of chromosome 21 in leukemogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Down syndrome and acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Array comparative genome hybridization analysis of acute lymphoblastic leukaemia and acute megakaryoblastic leukaemia in patients with Down syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

B-cell precursor t(8;14)(q11;q32)-positive acute lymphoblastic leukemia in children is strongly associated with Down syndrome or with a concomitant Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Down syndrome, drug metabolism and chromosome 21.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0765-3

21 January 2018

The immune system and susceptibility to infections in Down's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21286878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21286878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical aspects of Down's syndrome from infancy to adult life

1 reference

https://pubmed.ncbi.nlm.nih.gov/21286878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21286878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute leukaemia in children with Down syndrome: a population-based Nordic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21286878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21286878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952

1 reference

https://pubmed.ncbi.nlm.nih.gov/21286878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-011-0765-3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/21286878

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53270825&oldid=1586488723"